CS logo
small CS logo
Centro Investigacion Clinica del Sur

Temuco, Chile

About Centro Investigacion Clinica del Sur


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centro Investigacion Clinica del Sur


During the past decade, Centro Investigacion Clinica del Sur conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Investigacion Clinica del Sur" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Centro Investigacion Clinica del Sur


According to Clinical.Site data, the most researched conditions in "Centro Investigacion Clinica del Sur" are "Cardiovascular Disease" (1 trials), "Castration-Resistant Prostate Cancer" (1 trials), "High Cardiovascular Risk" (1 trials), "Metastatic Renal Cell Carcinoma" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Centro Investigacion Clinica del Sur" in a lesser frequency.

Clinical Trials Intervention Types at Centro Investigacion Clinica del Sur


Most popular intervention types in "Centro Investigacion Clinica del Sur" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Enzalutamide" (1 trials), "Lorcaserin hydrochloride" (1 trials), "bempegaldesleukin" (1 trials) and "cabozantinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centro Investigacion Clinica del Sur


The vast majority of trials in "Centro Investigacion Clinica del Sur" are 2 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Centro Investigacion Clinica del Sur


Currently, there are NaN active trials in "Centro Investigacion Clinica del Sur". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centro Investigacion Clinica del Sur, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Centro Investigacion Clinica del Sur, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".